Search

Search Results

Results 6951 - 6960 of 7434 for autoimmune

Cabenuva

Drug - 24 Apr 2026

Consumer Medicine Information (CMI) about Cabenuva intended for persons living in Australia.
How Indoor Air Quality and Building Design Shape Human Health

Health - 20 Apr 2026

Urban environments shape microbial exposure through building design, occupancy, ventilation, moisture, and contact with green space, with important consequences for infection risk, immune development,...
New directions in cell therapy: iPSC platforms and in vivo reprogramming

White Paper - 6 Apr 2026

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science behind these emerging strategies.
Edurant

Drug - 3 Mar 2026

Consumer Medicine Information (CMI) about Edurant intended for persons living in Australia.
Prezista

Drug - 27 Feb 2026

Consumer Medicine Information (CMI) about Prezista intended for persons living in Australia.
Prezcobix

Drug - 27 Feb 2026

Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
Abrysvo

Drug - 23 Feb 2026

Consumer Medicine Information (CMI) about Abrysvo intended for persons living in Australia.
Enabling large-scale iPSC-derived islet differentiation with GMP activin A and KGF

White Paper - 22 Jan 2026

Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes therapeutics.
What role does Cathepsin B play in arthritis & inflammation studies?

White Paper - 7 Jan 2026

Cathepsin B belongs to a family of lysosomal cysteine proteases (enzymes that break down proteins) present inside the cell.
Ixifi

Drug - 18 Dec 2025

Consumer Medicine Information (CMI) about Ixifi intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.